Decision-making behavior of blood glucose management and its influencing factors in pregnant women with gestational diabetes mellitus
Xu S, Wang J, Wang Y, et al.
BMC Pregnancy Childbirth. 2025;25(1):83.
Leggi
Impact of time in tight range on all-cause and cardiovascular mortality in type 2 diabetes: a prospective cohort study
Cai J, Liu J, Lu J, et al.
Diabetes Obes Metab. Pub. online 27 Jan 2025.
Leggi
I AMD Family – Riflessioni sull’indirizzo societario, sul posizionamento attuale e futuro di AMD | 5 febbraio 2025 – Roma
Leggi
AIFA: ll CdA AIFA approva la rimborsabilità, in tutte le Regioni, del farmaco BAQSIMI (glucagone spray nasale) e di due farmaci per il trattamento del diabete mellito (MOUNJARO e AWIQLI)
29/01/2025
Leggi
Diabetes risk after treatment for childhood and young adult cancer
Cromie KJ, Murray RD, Ajjan RA, et al.
Diabetes Care. 2025:dc242171.
Leggi
Long-term improvements in glycemia and user-reported outcomes associated with open-source automated insulin delivery systems in adults with type 1 diabetes in the United Kingdom: a real-world observational study
Liarakos AL, Crabtree TSJ, Hussain S, et al.
Diabetes Technol Ther. Pub. online 27 Jan 2025.
Leggi
Dapagliflozin plus calorie restriction for remission of type 2 diabetes: multicentre, double blind, randomised, placebo controlled trial
Liu Y, Chen Y, Ma J, et al.
BMJ. 2025;388:e081820.
Leggi
Residual C-peptide secretion is associated with better CGM-metrics in adults with short-lasting type 1 diabetes
Amendolara R, Zampetti S, Siena A, et al.
Diabetes Res Clin Pract. 2025:112006.
Leggi
Association between sarcopenia and weight-adjusted waist index in male patients with type 2 diabetes
Xiang Y, Wang Z, Xu J, et al.
BMC Endocr Disord. 2025;25(1):20.
Leggi
Achievement of HbA1c and weight targets in adults with type 2 diabetes on once weekly injectable glucagon-like peptide-1 receptor agonist therapy in UK primary care: a retrospective, real-world study
Gulati K, Wijndaele K, Webb J, et al.
Diabetes Obes Metab. Pub. online 22 Jan 2025.
Leggi